✦ LIBER ✦

Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro

✍ Scribed by Ma, Cuiling; Lin, Hong; Leonard, Stephen S; Shi, Xianglin; Ye, Jianping; Luo, Jia

Book ID: 110067768
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 250 KB
Volume: 22
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1206675

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of ErbB-2 overexpression on mito

Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells

✍ Timms, John F; White, Sarah L; O'Hare, Michael J; Waterfield, Michael D 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 447 KB

Targeting endothelin A receptor enhances

Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

✍ Jeanett Fischgräbe; Martin Götte; Katharina Michels; Ludwig Kiesel; Pia Wülfing 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev

Association of in vitro invasiveness and

Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor‐1 in human breast cancer cell lines

✍ Dan Tong; Klaus Czerwenka; Jan Sedlak; Christian Schneeberger; Ingrid Schiebel; 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 86 KB

CCAAT/enhancer binding protein δ (C/EBPδ

CCAAT/enhancer binding protein δ (C/EBPδ) regulation and expression in human mammary epithelial cells: I. “Loss of function” alterations in the C/EBPδ growth inhibitory pathway in breast cancer cell lines

✍ G.S. Sivko; J.W. DeWille 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in